Minimal Invasive Treatment of Achilles Tendinopathy: Focus on Percutaneous Release (Maffulli)
NCT ID: NCT04793971
Last Updated: 2021-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2014-11-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Rehabilitation After Achilles Tendon Rupture Repair: The Role of Blood Flow Restriction Training in Tendon and Muscle Recovery
NCT07131787
Biomechanics and Intrinsic Foot Muscle Roles in Subjects With Chronic Ankle Instability
NCT05815576
High Volume Injection in Mid Portion AChilles Tendinopathy
NCT06774066
Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture
NCT06434272
Use of Blood Flow Restriction Therapy in Perioperative Rehabilitation Following Achilles Tendon Rupture
NCT04492059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Approving by the Ethical Committee of UZLeuven is pending.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
postoperative cases
patients that underwent percutaneous release of the paratenon for chronic midportion Achilles tendinopathy
percutaneous paratenon release
percutaneous paratenon release for chronic midportion Achilles tendinopathy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
percutaneous paratenon release
percutaneous paratenon release for chronic midportion Achilles tendinopathy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* open intervention
* (partial) Achilles tendon rupture
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giovanni Matricali, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Foot and ankle surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals of Leuven
Pellenberg, Vlaams-Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S57392
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.